ArticleJMIR research protocols2026
Clinical Evidence Profile of Oral Chinese Patent Ethnomedicines: Protocol for a Scoping Review and Evidence Map.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chinese patent ethnomedicines (CPEs), a form of traditional Chinese patent medicine, originate from the traditional medicines of ethnic minority groups and are widely used in clinical practice. However, existing evidence to support their application remains unclear. Therefore, to address this gap, this comprehensive scoping review will be performed to provide an overview of the available evidence on CPE preparations. Objective: This review aims to provide the evidence profile for oral CPEs. This study will elucidate the current state of the evidence with respect to these medicines and identify research gaps. The detailed steps for conducting this review are outlined in this protocol. This review will contribute to a better understanding of CPEs. Methods: This review will include clinical studies of CPEs irrespective of study design. The frameworks described by Arksey and O'Malley, Levac et al, and the Joanna Briggs Institute will be used to guide this scoping review. This review will involve six steps: (1) identifying the research question; (2) collecting information about CPEs from national related drug catalogs; (3) searching MEDLINE (via PubMed), Embase, Web of Science, Cochrane Library, and Chinese databases from inception to February 2025 to identify relevant publications; (4) screening the literature against the eligibility criteria; (5) extracting data using a predefined standardized data extraction form; and (6) summarizing, discussing, analyzing, and reporting the results. We will also present the results via data visualization techniques. Results: We will synthesize data on CPEs by conducting the scoping review, drawing the evidence maps, identifying the clinical characteristics of CPEs and how they relate to the adverse events, and highlighting the limitations and gaps in the literature. We expect to publish the results in 2027. Conclusions: The data obtained through this review could inform future research involving CPEs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.